Callender, C. J., Iglehart, B., Bagnasco, S. J., Bettinotti, M. P., & Jackson, A. M. (2019). OR22 Use of donor-derived cell-free DNA (CFDNA) and donor-specific HLA antibody (DSA) testing as companion diagnostics following hla incompatible kidney transplantation. In Human Immunology (Vol. 80, pp. 28–28). Elsevier BV. https://doi.org/10.1016/j.humimm.2019.07.024

Callender, Carly J., Brian Iglehart, Serena J. Bagnasco, Maria P. Bettinotti, and Annette M. Jackson. “OR22 Use of donor-derived cell-free DNA (CFDNA) and donor-specific HLA antibody (DSA) testing as companion diagnostics following hla incompatible kidney transplantation.” In Human Immunology, 80:28–28. Elsevier BV, 2019. https://doi.org/10.1016/j.humimm.2019.07.024.

Callender CJ, Iglehart B, Bagnasco SJ, Bettinotti MP, Jackson AM. OR22 Use of donor-derived cell-free DNA (CFDNA) and donor-specific HLA antibody (DSA) testing as companion diagnostics following hla incompatible kidney transplantation. In: Human Immunology. Elsevier BV; 2019. p. 28–28.

Callender, Carly J., et al. “OR22 Use of donor-derived cell-free DNA (CFDNA) and donor-specific HLA antibody (DSA) testing as companion diagnostics following hla incompatible kidney transplantation.” Human Immunology, vol. 80, Elsevier BV, 2019, pp. 28–28. Crossref, doi:10.1016/j.humimm.2019.07.024.

Callender CJ, Iglehart B, Bagnasco SJ, Bettinotti MP, Jackson AM. OR22 Use of donor-derived cell-free DNA (CFDNA) and donor-specific HLA antibody (DSA) testing as companion diagnostics following hla incompatible kidney transplantation. Human Immunology. Elsevier BV; 2019. p. 28–28.